SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-135267
Filing Date
2024-05-09
Accepted
2024-05-09 16:10:07
Documents
15
Period of Report
2024-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d837604d8k.htm   iXBRL 8-K 24633
2 EX-99.1 d837604dex991.htm EX-99.1 29196
6 GRAPHIC g837604dsp04.jpg GRAPHIC 5470
  Complete submission text file 0001193125-24-135267.txt   184713

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aclx-20240509.xsd EX-101.SCH 2837
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aclx-20240509_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aclx-20240509_pre.xml EX-101.PRE 10803
18 EXTRACTED XBRL INSTANCE DOCUMENT d837604d8k_htm.xml XML 3494
Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 24930642
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)